ProSensa Holding N.V. (RNA) To Provide Corporate Update To Key Stakeholders
1/14/2014 9:27:09 AM
Leiden, The Netherlands, Jan. 13, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA), the Dutch biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high unmet medical need, will be providing updates to both the financial and patient communities regarding drisapersen.
Help employers find you! Check out all the jobs and post your resume.
comments powered by